Atlas Trials

Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism

Clinical trial NCT04246073 · UNKNOWN

Trial details

NCT number
NCT04246073
Sponsor
Hellenic Society of Surgical Oncology
Status
UNKNOWN
Study type
OBSERVATIONAL
CancerCancer DiagnosisThromboembolism
Start date
2019-02-01
Primary completion
2020-10-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.